Cadila - Latest News on Cadila | Read Breaking News on Zee News

Zydus launches diabetes treatment drug Lipaglyn

Last Updated: Monday, September 16, 2013, 19:37

Pharmaceutical entity Zydus group today said it has launched Lipaglyn, its patented new drug for treatment of diabetes.

Zydus Cadila gets DCGI nod for launch of its NCE for diabetes

Last Updated: Wednesday, June 05, 2013, 16:09

Cadila Healthcare today said Indian drug regulator has approved its new chemical entity, Lipaglyn to be used for treating a type of diabetes for launch in the country.

Zydus Cadila launches migraine drug in the US

Last Updated: Friday, May 17, 2013, 00:26

Drug firm Zydus Cadila today said it has launched Zolmitriptan orally disintegrating tablets, a migraine drug, in the American market after getting approval from the US health regulator.

Zydus Cadila gets USFDA nod for schizophrenia drug

Last Updated: Wednesday, August 01, 2012, 00:39

Drug firm Zydus Cadila today said it has received the US health regulator`s approval to market aripiprazole orally disintegrating tablets, used in treating schizophrenia, in the American market.

Drugmakers give swine flu vaccines a second shot

Last Updated: Friday, April 27, 2012, 19:04

Drugmakers are looking to recover some of their investments amid a new outbreak of the deadly virus in India.

Zydus Cadila H1N1 vaccine trial begins

Last Updated: Wednesday, January 06, 2010, 00:00

A new H1N1 vaccine may hit medical stores by April and clinical trials have already begun, its makers today said.

Cadila launches new drug for TB treatment

Last Updated: Saturday, October 31, 2009, 00:00

Cadila Pharmaceuticals Ltd, a Gujarat-based pharma company, on Saturday launched Risorine, the first indigenously prepared drug for treatment of tuberculosis in the country.

Cadila to apply for clinical trials for swine flu vaccine

Last Updated: Tuesday, August 11, 2009, 00:00

With an aim to launch vaccine for Influenza H1N1 A Virus (swine flu) in India, Cadila Pharmaceutical will seek the government`s nod in two days for initiating clinical trials in this regard.

First Prev 1 Next Last